ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025

NOTICE OF BOARD MEETING

Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026

VOLUNTARY ANNOUNCEMENT TRANSFER OF SHARES BY CONTROLLING SHAREHOLDER

VOLUNTARY ANNOUNCEMENT TRANSFER OF SHARES BY CONTROLLING SHAREHOLDER

VOLUNTARY ANNOUNCEMENT FINANCE LEASE AGREEMENT

ANNOUNCEMENT (1) UNUSUAL MOVEMENT IN TRADING VOLUME AND (2) DENOSUMAB (60MG) APPROVED FOR MARKETING IN BOLIVIA

Boan's Denosumab (60mg) Approved for Market Launch in Bolivia

Boan Biotech announced that its self-developed Denosumab Injection 60mg (BA6101) has officially received approval for market from the Bolivian National Agency of Medicines and Health Technologies (Age...

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025